Identification of Phytochemicals Targeting c-Met Kinase Domain using Consensus Docking and Molecular Dynamics Simulation Studies
- 430 Downloads
c-Met receptor tyrosine kinase is a proto-oncogene whose aberrant activation is attributed to a lower rate of survival in most cancers. Natural product-derived inhibitors known as “fourth generation inhibitors” constitute more than 60% of anticancer drugs. Furthermore, consensus docking approach has recently been introduced to augment docking accuracy and reduce false positives during a virtual screening. In order to obtain novel small-molecule Met inhibitors, consensus docking approach was performed using Autodock Vina and Autodock 4.2 to virtual screen Naturally Occurring Plant-based Anti-cancer Compound–Activity–Target database against active and inactive conformation of c-Met kinase domain structure. Two hit molecules that were in line with drug-likeness criteria, desired docking score, and binding pose were subjected to molecular dynamics simulations to elucidate intermolecular contacts in protein–ligand complexes. Analysis of molecular dynamics simulations and molecular mechanics Poisson–Boltzmann surface area studies showed that ZINC08234189 is a plausible inhibitor for the active state of c-Met, whereas ZINC03871891 may be more effective toward active c-Met kinase domain compared to the inactive form due to higher binding energy. Our analysis showed that both the hit molecules formed hydrogen bonds with key residues of the hinge region (P1158, M1160) in the active form, which is a hallmark of kinase domain inhibitors. Considering the pivotal role of HGF/c-Met signaling in carcinogenesis, our results propose ZINC08234189 and ZINC03871891 as the therapeutic options to surmount Met-dependent cancers.
KeywordsConsensus docking c-Met inhibitor Molecular dynamics simulation Binding free energy Natural products
This research has been supported by Grant Number 93013896 from Iran National Science Foundation (INSF) and 94-01-33-28717 from Deputy of Research, Tehran University of Medical Science.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no competing interests.
- 6.Akl, M. R., Ayoub, N. M., Mohyeldin, M. M., Busnena, B. A., Foudah, A. I., Liu, Y.-Y., & El Sayed, K. A. (2014). Olive phenolics as c-Met inhibitors: (−)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. PLoS One, 9, e97622.CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Lee, W.-J., Chen, W.-K., Wang, C.-J., Lin, W.-L., & Tseng, T.-H. (2008). Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells. Toxicology and Applied Pharmacology, 226, 178–191.CrossRefPubMedGoogle Scholar
- 20.Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012). ZINC: A free tool to discover chemistry for biology. J Chem Inf Model 52, 1757–1768.Google Scholar
- 23.Liang, Z., Zhang, D., Ai, J., Chen, L., Wang, H., Kong, X., Zheng, M., Liu, H., Luo, C., Geng, M., Jiang, H., & Chen, K. (2011). Identification and synthesis of N′-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase. Bioorganic & Medicinal Chemistry Letters, 21, 3749–3754.CrossRefGoogle Scholar
- 24.Schiering, N., Knapp, S., Marconi, M., Flocco, M. M., Cui, J., Perego, R., Rusconi, L., & Cristiani, C. (2003). Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a. Proceedings of the National Academy of Sciences of the United States of America, 100, 12654–12659.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Peach, M. L., Tan, N., Choyke, S. J., Giubellino, A., Athauda, G., Burke, Jr, T. R., Nicklaus, M. C., & Bottaro, D. P. (2009). Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening. Journal of Medicinal Chemistry, 52, 943–951.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., & van der Spoel, D. (2013). GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics (Oxford, England), 29, 845–854.CrossRefGoogle Scholar
- 35.Mohyeldin, M. M., Busnena, B. A., Akl, M. R., Dragoi, A. M., Cardelli, J. A., & El Sayed, K. A. (2016). Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer. European Journal of Medicinal Chemistry, 118, 299–315.CrossRefPubMedPubMedCentralGoogle Scholar